Get started
Author

Anjali Jain

The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
2015 · Andres J Yarur, Anjali Jain, et al. · Gut · 243
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn’s Disease
2017 · Robert Battat, Uri Kopylov, et al. · Clinical Gastroenterology and Hepatology · 239
Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
2015 · Andres J. Yarur, Maddie J. Kubiliun, et al. · Clinical Gastroenterology and Hepatology · 161
PDF
Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
2009 · Shannon M. Mumenthaler, Patricia Y.B. Ng, et al. · Molecular Cancer Therapeutics · 142
Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohnʼs Disease and Ulcerative Colitis
2016 · Andres J. Yarur, Anjali Jain, et al. · Inflammatory Bowel Diseases · 110
Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer
2005 · Moritz N Wente, Anjali Jain, et al. · Pancreas · 94
Mechanism of synergy between TATA and initiator: synergistic binding of TFIID following a putative TFIIA-induced isomerization
1997 · Katayoon H. Emami, Anjali Jain, et al. · Genes & Development · 94
Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn’s Disease Based on Serum Levels of Proteins
2019 · Geert D’Haens, Orlaith Kelly, et al. · Gastroenterology · 87
PDF
Epithelial membrane protein-1 is a biomarker of gefitinib resistance
2005 · Anjali Jain, Charles A. Tindell, et al. · Proceedings of the National Academy of Sciences · 87
Cancer-Associated Fibroblasts Derived from EGFR-TKI–Resistant Tumors Reverse EGFR Pathway Inhibition by EGFR-TKIs
2010 · Sheldon R. Mink, Surabhi Vashistha, et al. · Molecular Cancer Research · 84
PDF
2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth
2005 · Noriyuki Takai, Anjali Jain, et al. · Cancer · 70
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies
2005 · I Laux, A Jain, et al. · British Journal of Cancer · 69
PDF
HER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular Proliferation
2010 · Anjali Jain, Elicia Penuel, et al. · Cancer Research · 66
PDF
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease
2019 · Ryan C Ungaro, Andres Yarur, et al. · Journal of Crohn s and Colitis · 65
Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohnʼs Disease
2016 · Andres J. Yarur, Maria A. Quintero, et al. · Inflammatory Bowel Diseases · 59
Identification of an Androgen-Dependent Enhancer within the Prostate Stem Cell Antigen Gene
2002 · Anjali Jain, Amanda Lam, et al. · Molecular Endocrinology · 53
PDF
Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
2019 · Andres J. Yarur, Alexandra Bruss, et al. · Digestive Diseases and Sciences · 49
Raloxifene, an oestrogen‐receptor‐β‐targeted therapy, inhibits androgen‐independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial
2005 · RONALD L. SHAZER, ANJALI JAIN, et al. · British Journal of Urology · 47
An unusual 30-kDa protein binding to the polyhedrin gene promoter of Autographa californica nuclear polyhedrosis virus.
1994 · S. Burma, B. Mukherjee, et al. · Journal of Biological Chemistry · 46
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis
2018 · Robert Battat, Parambir S Dulai, et al. · Inflammatory Bowel Diseases · 45
PDF
A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
2013 · Jeeyun Lee, Sung Kim, et al. · PLoS ONE · 39
PDF
Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARγ
2004 · Michael Hedvat, Anjali Jain, et al. · Cancer Cell · 32
PDF
Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor
2021 · Niels Vande Casteele, Maria T. Abreu, et al. · Clinical Gastroenterology and Hepatology · 30
PDF
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease
2017 · Giorgia Bodini, Edoardo G. Giannini, et al. · Digestive and Liver Disease · 27
Bifunctionality of the AcMNPV Homologous Region Sequence ( hr 1): Enhancer and ori Functions Have Different Sequence Requirements
1996 · Saman Habib, Seema Pandey, et al. · DNA and Cell Biology · 27
Works count: 148
Citation count: 2,519
H-index: 26
I10-index: 45
Year
Topic
Type